MediSpend Analysis
What is MediSpend?
MediSpend provides end-to-end commercial compliance solutions for pharmaceutical, medical device, and biotech companies. Their platform streamlines compliance processes across stakeholder engagement, funding, and transparency reporting. The company has merged with RLDatix Life Sciences and acquired Alucio to expand AI-enabled engagement capabilities.
Location
Portsmouth, United States
Employees
51-200
Founded
2011
Parent Company
Susquehanna Growth Equity
Address
1000 Market Street, Suite 200, Portsmouth, NH 03801, USA
Latest Funding Round Size
Private Equity Round
Public Company Status
Private
State of Headquarters
New Hampshire
Product Features & Capabilities
- Compliant Consultant Engagement
- Stakeholder Engagement
- KOL Management
- HCP Portal
- FMV Data Management
- Events Management
- Configurable Workflows
- Logistics
- Embedded Compliance
- Funding Management
- Grants Management
- Study/IIS Management
- Program Insights
- Transparency Reporting
- Reporting-as-a-Service
- Transparency Solution
- Managed Services
- Advanced Analytics
- Third-Party Due Diligence
- Risk Assessments & Scoring
- Corruption Index
- Questionnaires
- Annual Re-Certification
- Contracting
Use Cases
Manage HCP and KOL engagement with compliant workflows; Automate transparency reporting for Sunshine Act compliance; Conduct third-party due diligence with corruption scoring; Track grants and study funding from submission to closeout; Monitor FMV data across global markets
Other Considerations
Merged with RLDatix Life Sciences; Acquired Alucio to expand AI-enabled stakeholder engagement; Recognized by industry leaders for data accuracy and ease of use; Trusted by medical device and pharmaceutical companies for compliance reporting
See something that needs updating? Suggest edits to this profile.